Statistics for Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.
Total visits
| views | |
|---|---|
| Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway. | 155 |
Total visits per month
| views | |
|---|---|
| September 2024 | 10 |
| October 2024 | 11 |
| November 2024 | 5 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
Top country views
| views | |
|---|---|
| United States | 53 |
| China | 27 |
| Portugal | 11 |
| Canada | 8 |
| Australia | 7 |
| Brazil | 7 |
| Ukraine | 6 |
| Russia | 5 |
| Germany | 3 |
| United Kingdom | 3 |
| India | 3 |
| Ireland | 2 |
| Italy | 2 |
| Mongolia | 2 |
| Albania | 1 |
| Austria | 1 |
| Belgium | 1 |
| Bulgaria | 1 |
| Denmark | 1 |
| Hungary | 1 |
| Israel | 1 |
| Latvia | 1 |
| Pakistan | 1 |
| Poland | 1 |
| Turkey | 1 |